Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 9/2018

01-09-2018 | Original Article

Clinical and microbiological characteristics of peritoneal dialysis-related peritonitis caused by Escherichia coli in southern Taiwan

Authors: Wei-Hung Lin, Chin-Chung Tseng, An-Bang Wu, Yu-Tzu Chang, Te-Hui Kuo, Jo-Yen Chao, Ming-Cheng Wang, Jiunn-Jong Wu

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 9/2018

Login to get access

Abstract

Peritonitis is a serious complication and major cause of treatment failure in patients undergoing peritoneal dialysis (PD). Escherichia coli is the major pathogen in extraintestinal Gram-negative infections, including PD-related peritonitis. The outcomes of E. coli peritonitis in PD varied from relatively favorable outcomes to a higher incidence of treatment failure. The aim of this study was to investigate the impact of bacterial virulence and host characteristics on the outcomes of PD-related peritonitis caused by E. coli. From January 2000 to June 2016, a total of 47 episodes of monomicrobial and 10 episodes of polymicrobial E. coli PD-related peritonitis, as well as 89 episodes of monomicrobial Gram-positive (56 Staphylococcus spp. and 33 Streptococcus spp.) PD-related peritonitis cases, were retrospectively enrolled. Clinical features, E. coli bacterial virulence, and outcomes were analyzed. Compared to Streptococcus spp. peritonitis, E. coli peritonitis had a higher peritoneal catheter removal rate (38 versus 12%; P = 0.0115). Compared to the monomicrobial group, patients in polymicrobial group were older and had higher peritoneal catheter removal rate (80 versus 38%; P = 0.0324). Treatment failure of E. coli peritonitis was associated with more polymicrobial peritonitis and immunocompromised comorbidity, longer duration of PD therapy, and more antimicrobial resistance. E. coli isolates with more iron-related genes had higher prevalence of phylogenetic group B2 and papG II, iha, ompT, and usp genes. This study demonstrates the important roles of clinical and bacterial characteristics in the outcomes of monomicrobial and polymicrobial E. coli PD-related peritonitis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Oreopoulos DG, Tzamaloukas AH (2000) Peritoneal dialysis in the next millennium. Adv Ren Replace Ther 7(4):338–346CrossRefPubMed Oreopoulos DG, Tzamaloukas AH (2000) Peritoneal dialysis in the next millennium. Adv Ren Replace Ther 7(4):338–346CrossRefPubMed
2.
go back to reference Li PK, Szeto CC, Piraino B, de Arteaga J, Fan S, Figueiredo AE, Fish DN, Goffin E, Kim YL, Salzer W, Struijk DG, Teitelbaum I, Johnson DW (2016) ISPD peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int 36(5):481–508CrossRefPubMedPubMedCentral Li PK, Szeto CC, Piraino B, de Arteaga J, Fan S, Figueiredo AE, Fish DN, Goffin E, Kim YL, Salzer W, Struijk DG, Teitelbaum I, Johnson DW (2016) ISPD peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int 36(5):481–508CrossRefPubMedPubMedCentral
3.
go back to reference Bernardini J, Holley JL, Johnston JR, Perlmutter JA, Piraino B (1991) An analysis of ten-year trends in infections in adults on continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 36(1):29–34PubMed Bernardini J, Holley JL, Johnston JR, Perlmutter JA, Piraino B (1991) An analysis of ten-year trends in infections in adults on continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 36(1):29–34PubMed
4.
go back to reference Zelenitsky S, Barns L, Findlay I, Alfa M, Ariano R, Fine A, Harding G (2000) Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kidney Dis 36(5):1009–1013CrossRefPubMed Zelenitsky S, Barns L, Findlay I, Alfa M, Ariano R, Fine A, Harding G (2000) Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kidney Dis 36(5):1009–1013CrossRefPubMed
5.
go back to reference Huang ST, Chuang YW, Cheng CH, Wu MJ, Chen CH, Yu TM, Shu KH (2011) Evolution of microbiological trends and treatment outcomes in peritoneal dialysis-related peritonitis. Clin Nephrol 75(5):416–425CrossRefPubMed Huang ST, Chuang YW, Cheng CH, Wu MJ, Chen CH, Yu TM, Shu KH (2011) Evolution of microbiological trends and treatment outcomes in peritoneal dialysis-related peritonitis. Clin Nephrol 75(5):416–425CrossRefPubMed
6.
go back to reference Russo TA, Johnson JR (2003) Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect 5(5):449–456CrossRefPubMed Russo TA, Johnson JR (2003) Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect 5(5):449–456CrossRefPubMed
7.
go back to reference Szeto CC, Chow VC, Chow KM, Lai RW, Chung KY, Leung CB, Kwan BC, Li PK (2006) Enterobacteriaceae peritonitis complicating peritoneal dialysis: a review of 210 consecutive cases. Kidney Int 69(7):1245–1252CrossRefPubMed Szeto CC, Chow VC, Chow KM, Lai RW, Chung KY, Leung CB, Kwan BC, Li PK (2006) Enterobacteriaceae peritonitis complicating peritoneal dialysis: a review of 210 consecutive cases. Kidney Int 69(7):1245–1252CrossRefPubMed
8.
go back to reference Jarvis EM, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW (2010) Predictors, treatment, and outcomes of non-pseudomonas gram-negative peritonitis. Kidney Int 78(4):408–414CrossRefPubMed Jarvis EM, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW (2010) Predictors, treatment, and outcomes of non-pseudomonas gram-negative peritonitis. Kidney Int 78(4):408–414CrossRefPubMed
9.
go back to reference Wang MC, Tseng CC, Chen CY, Wu JJ, Huang JJ (2002) The role of bacterial virulence and host factors in patients with Escherichia coli bacteremia who have acute cholangitis or upper urinary tract infection. Clin Infect Dis 35(10):1161–1166CrossRefPubMed Wang MC, Tseng CC, Chen CY, Wu JJ, Huang JJ (2002) The role of bacterial virulence and host factors in patients with Escherichia coli bacteremia who have acute cholangitis or upper urinary tract infection. Clin Infect Dis 35(10):1161–1166CrossRefPubMed
10.
go back to reference Barretti P, Moraes TM, Camargo CH, Caramori JC, Mondelli AL, Montelli AC, da Cunha Mde L (2012) Peritoneal dialysis-related peritonitis due to Staphylococcus aureus: a single-center experience over 15 years. PLoS One 7:e31780CrossRefPubMedPubMedCentral Barretti P, Moraes TM, Camargo CH, Caramori JC, Mondelli AL, Montelli AC, da Cunha Mde L (2012) Peritoneal dialysis-related peritonitis due to Staphylococcus aureus: a single-center experience over 15 years. PLoS One 7:e31780CrossRefPubMedPubMedCentral
11.
go back to reference de Lourdes Ribeiro de Souza da Cunha M, Montelli AC, Fioravante AM, Neves Batalha JE, Teixeira Caramori JC, Barretti P (2005) Predictive factors of outcome following staphylococcal peritonitis in continuous ambulatory peritoneal dialysis. Clin Nephrol 64(5):378–382 de Lourdes Ribeiro de Souza da Cunha M, Montelli AC, Fioravante AM, Neves Batalha JE, Teixeira Caramori JC, Barretti P (2005) Predictive factors of outcome following staphylococcal peritonitis in continuous ambulatory peritoneal dialysis. Clin Nephrol 64(5):378–382
12.
go back to reference Szeto CC, Kwan BC, Chow KM, Lau MF, Law MC, Chung KY, Leung CB, Li PK (2008) Coagulase negative staphylococcal peritonitis in peritoneal dialysis patients: review of 232 consecutive cases. Clin J Am Soc Nephrol 3(1):91–97CrossRefPubMedPubMedCentral Szeto CC, Kwan BC, Chow KM, Lau MF, Law MC, Chung KY, Leung CB, Li PK (2008) Coagulase negative staphylococcal peritonitis in peritoneal dialysis patients: review of 232 consecutive cases. Clin J Am Soc Nephrol 3(1):91–97CrossRefPubMedPubMedCentral
13.
go back to reference Camargo CH, Cunha Mde L, Caramori JC, Mondelli AL, Montelli AC, Barretti P (2014) Peritoneal dialysis-related peritonitis due to coagulase-negative Staphylococcus: a review of 115 cases in a Brazilian center. Clin J Am Soc Nephrol 9(6):1074–1081CrossRefPubMedPubMedCentral Camargo CH, Cunha Mde L, Caramori JC, Mondelli AL, Montelli AC, Barretti P (2014) Peritoneal dialysis-related peritonitis due to coagulase-negative Staphylococcus: a review of 115 cases in a Brazilian center. Clin J Am Soc Nephrol 9(6):1074–1081CrossRefPubMedPubMedCentral
14.
go back to reference O’Shea S, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW (2009) Streptococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 287 cases. BMC Nephrol 10:19CrossRefPubMedPubMedCentral O’Shea S, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW (2009) Streptococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 287 cases. BMC Nephrol 10:19CrossRefPubMedPubMedCentral
15.
go back to reference Shukla A, Abreu Z, Bargman JM (2006) Streptococcal PD peritonitis--a 10-year review of one centre's experience. Nephrol Dial Transplant 21(12):3545–3549CrossRefPubMed Shukla A, Abreu Z, Bargman JM (2006) Streptococcal PD peritonitis--a 10-year review of one centre's experience. Nephrol Dial Transplant 21(12):3545–3549CrossRefPubMed
16.
go back to reference Kiernan L, Finkelstein FO, Kliger AS, Gorban-Brennan N, Juergensen P, Mooraki A, Brown E (1995) Outcome of polymicrobial peritonitis in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 25(3):461–464CrossRefPubMed Kiernan L, Finkelstein FO, Kliger AS, Gorban-Brennan N, Juergensen P, Mooraki A, Brown E (1995) Outcome of polymicrobial peritonitis in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 25(3):461–464CrossRefPubMed
17.
go back to reference Barraclough K, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW (2010) Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes. Am J Kidney Dis 55(1):121–131CrossRefPubMed Barraclough K, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW (2010) Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes. Am J Kidney Dis 55(1):121–131CrossRefPubMed
18.
go back to reference Bunke CM, Brier ME, Golper TA (1997) Outcomes of single organism peritonitis in peritoneal dialysis: gram negatives versus gram positives in the network 9 peritonitis study. Kidney Int 52(2):524–529CrossRefPubMed Bunke CM, Brier ME, Golper TA (1997) Outcomes of single organism peritonitis in peritoneal dialysis: gram negatives versus gram positives in the network 9 peritonitis study. Kidney Int 52(2):524–529CrossRefPubMed
19.
go back to reference Valdés-Sotomayor J, Cirugeda A, Bajo MA, del Peso G, Escudero E, Sánchez-Tomero JA, Selgas R, Grupo de Estudios Peritoneales de Madrid (2003) Increased severity of Escherichia coli peritonitis in peritoneal dialysis patients independent of changes in in vitro antimicrobial susceptibility testing. Perit Dial Int 23(5):450–455PubMed Valdés-Sotomayor J, Cirugeda A, Bajo MA, del Peso G, Escudero E, Sánchez-Tomero JA, Selgas R, Grupo de Estudios Peritoneales de Madrid (2003) Increased severity of Escherichia coli peritonitis in peritoneal dialysis patients independent of changes in in vitro antimicrobial susceptibility testing. Perit Dial Int 23(5):450–455PubMed
20.
go back to reference Pérez-Fontán M, Lueiro F (2006) Escherichia coli peritonitis in patients undergoing peritoneal dialysis: a serious problem that may get worse. Perit Dial Int 26(2):174–177PubMed Pérez-Fontán M, Lueiro F (2006) Escherichia coli peritonitis in patients undergoing peritoneal dialysis: a serious problem that may get worse. Perit Dial Int 26(2):174–177PubMed
21.
go back to reference Feng X, Yang X, Yi C, Guo Q, Mao H, Jiang Z, Li Z, Chen D, Cui Y, Yu X (2014) Escherichia coli peritonitis in peritoneal dialysis: the prevalence, antibiotic resistance and clinical outcomes in a South China dialysis center. Perit Dial Int 34(3):308–316CrossRefPubMedPubMedCentral Feng X, Yang X, Yi C, Guo Q, Mao H, Jiang Z, Li Z, Chen D, Cui Y, Yu X (2014) Escherichia coli peritonitis in peritoneal dialysis: the prevalence, antibiotic resistance and clinical outcomes in a South China dialysis center. Perit Dial Int 34(3):308–316CrossRefPubMedPubMedCentral
22.
go back to reference Yip T, Tse KC, Ng F, Hung I, Lam MF, Tang S, Lui SL, Lai KN, Chan TM, Lo WK (2011) Clinical course and outcomes of single-organism Enterococcus peritonitis in peritoneal dialysis patients. Perit Dial Int 31(5):522–528CrossRefPubMed Yip T, Tse KC, Ng F, Hung I, Lam MF, Tang S, Lui SL, Lai KN, Chan TM, Lo WK (2011) Clinical course and outcomes of single-organism Enterococcus peritonitis in peritoneal dialysis patients. Perit Dial Int 31(5):522–528CrossRefPubMed
23.
24.
go back to reference Wang MC, Lin WH, Tseng CC, Wu AB, Teng CH, Yan JJ, Wu JJ (2013) Role of K1 capsule antigen in cirrhotic patients with Escherichia coli spontaneous bacterial peritonitis in southern Taiwan. Eur J Clin Microbiol Infect Dis 32(3):407–412CrossRefPubMed Wang MC, Lin WH, Tseng CC, Wu AB, Teng CH, Yan JJ, Wu JJ (2013) Role of K1 capsule antigen in cirrhotic patients with Escherichia coli spontaneous bacterial peritonitis in southern Taiwan. Eur J Clin Microbiol Infect Dis 32(3):407–412CrossRefPubMed
25.
go back to reference Mao BH, Chang YF, Scaria J, Chang CC, Chou LW, Tien N, Wu JJ, Tseng CC, Wang MC, Chang CC, Hsu YM, Teng CH (2012) Identification of Escherichia coli genes associated with urinary tract infections. J Clin Microbiol 50(2):449–456CrossRefPubMedPubMedCentral Mao BH, Chang YF, Scaria J, Chang CC, Chou LW, Tien N, Wu JJ, Tseng CC, Wang MC, Chang CC, Hsu YM, Teng CH (2012) Identification of Escherichia coli genes associated with urinary tract infections. J Clin Microbiol 50(2):449–456CrossRefPubMedPubMedCentral
26.
go back to reference Clermont O, Bonacorsi S, Bingen E (2000) Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66:4555–4558CrossRefPubMedPubMedCentral Clermont O, Bonacorsi S, Bingen E (2000) Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66:4555–4558CrossRefPubMedPubMedCentral
27.
go back to reference Kao CY, Sheu BS, Sheu SM, Yang HB, Chang WL, Cheng HC, Wu JJ (2012) Higher motility enhances bacterial density and inflammatory response in dyspeptic patients infected with Helicobacter pylori. Helicobacter 17(6):411–416CrossRefPubMed Kao CY, Sheu BS, Sheu SM, Yang HB, Chang WL, Cheng HC, Wu JJ (2012) Higher motility enhances bacterial density and inflammatory response in dyspeptic patients infected with Helicobacter pylori. Helicobacter 17(6):411–416CrossRefPubMed
28.
29.
go back to reference Lin WH, Tseng CC, Wu AB, Yang DC, Cheng SW, Wang MC, Wu JJ (2015) Clinical and microbiological characteristics of peritoneal dialysis-related peritonitis caused by Klebsiella pneumoniae in southern Taiwan. J Microbiol Immunol Infect 48(3):276–283CrossRefPubMed Lin WH, Tseng CC, Wu AB, Yang DC, Cheng SW, Wang MC, Wu JJ (2015) Clinical and microbiological characteristics of peritoneal dialysis-related peritonitis caused by Klebsiella pneumoniae in southern Taiwan. J Microbiol Immunol Infect 48(3):276–283CrossRefPubMed
30.
go back to reference Prasad KN, Singh K, Rizwan A, Mishra P, Tiwari D, Prasad N, Gupta A (2014) Microbiology and outcomes of peritonitis in northern India. Perit Dial Int 34(2):188–194CrossRefPubMedPubMedCentral Prasad KN, Singh K, Rizwan A, Mishra P, Tiwari D, Prasad N, Gupta A (2014) Microbiology and outcomes of peritonitis in northern India. Perit Dial Int 34(2):188–194CrossRefPubMedPubMedCentral
31.
go back to reference Holley JL, Bernardini J, Piraino B (1992) Polymicrobial peritonitis in patients on continuous peritoneal dialysis. Am J Kidney Dis 19(2):162–166CrossRefPubMed Holley JL, Bernardini J, Piraino B (1992) Polymicrobial peritonitis in patients on continuous peritoneal dialysis. Am J Kidney Dis 19(2):162–166CrossRefPubMed
32.
go back to reference Kim GC, Korbet SM (2000) Polymicrobial peritonitis in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 36(5):1000–1008CrossRefPubMed Kim GC, Korbet SM (2000) Polymicrobial peritonitis in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 36(5):1000–1008CrossRefPubMed
33.
go back to reference Szeto CC, Chow KM, Wong TY, Leung CB, Li PK (2002) Conservative management of polymicrobial peritonitis complicating peritoneal dialysis--a series of 140 consecutive cases. Am J Med 113(9):728–733CrossRefPubMed Szeto CC, Chow KM, Wong TY, Leung CB, Li PK (2002) Conservative management of polymicrobial peritonitis complicating peritoneal dialysis--a series of 140 consecutive cases. Am J Med 113(9):728–733CrossRefPubMed
35.
go back to reference Lau CK, Krewulak KD, Vogel HJ (2016) Bacterial ferrous iron transport: the Feo system. FEMS Microbiol Rev 40(2):273–298CrossRefPubMed Lau CK, Krewulak KD, Vogel HJ (2016) Bacterial ferrous iron transport: the Feo system. FEMS Microbiol Rev 40(2):273–298CrossRefPubMed
36.
go back to reference Watts RE, Totsika M, Challinor VL, Mabbett AN, Ulett GC, De Voss JJ, Schembri MA (2012) Contribution of siderophore systems to growth and urinary tract colonization of asymptomatic bacteriuria Escherichia coli. Infect Immun 80(1):333–344CrossRefPubMedPubMedCentral Watts RE, Totsika M, Challinor VL, Mabbett AN, Ulett GC, De Voss JJ, Schembri MA (2012) Contribution of siderophore systems to growth and urinary tract colonization of asymptomatic bacteriuria Escherichia coli. Infect Immun 80(1):333–344CrossRefPubMedPubMedCentral
37.
go back to reference Le Gall T, Clermont O, Gouriou S, Picard B, Nassif X, Denamur E, Tenaillon O (2007) Extraintestinal virulence is a coincidental by-product of commensalism in B2 phylogenetic group Escherichia coli strains. Mol Biol Evol 24(11):2373–2384CrossRefPubMed Le Gall T, Clermont O, Gouriou S, Picard B, Nassif X, Denamur E, Tenaillon O (2007) Extraintestinal virulence is a coincidental by-product of commensalism in B2 phylogenetic group Escherichia coli strains. Mol Biol Evol 24(11):2373–2384CrossRefPubMed
38.
go back to reference Luo Y, Ma Y, Zhao Q, Wang L, Guo L, Ye L, Zhang Y, Yang J (2012) Similarity and divergence of phylogenies, antimicrobial susceptibilities, and virulence factor profiles of Escherichia coli isolates causing recurrent urinary tract infections that persist or result from reinfection. J Clin Microbiol 50(12):4002–4007CrossRefPubMedPubMedCentral Luo Y, Ma Y, Zhao Q, Wang L, Guo L, Ye L, Zhang Y, Yang J (2012) Similarity and divergence of phylogenies, antimicrobial susceptibilities, and virulence factor profiles of Escherichia coli isolates causing recurrent urinary tract infections that persist or result from reinfection. J Clin Microbiol 50(12):4002–4007CrossRefPubMedPubMedCentral
39.
go back to reference Russo TA, McFadden CD, Carlino-MacDonald UB, Beanan JM, Barnard TJ, Johnson JR (2002) IroN functions as a siderophore receptor and is a urovirulence factor in an extraintestinal pathogenic isolate of Escherichia coli. Infect Immun 70(12):7156–7160CrossRefPubMedPubMedCentral Russo TA, McFadden CD, Carlino-MacDonald UB, Beanan JM, Barnard TJ, Johnson JR (2002) IroN functions as a siderophore receptor and is a urovirulence factor in an extraintestinal pathogenic isolate of Escherichia coli. Infect Immun 70(12):7156–7160CrossRefPubMedPubMedCentral
40.
go back to reference Russo TA, McFadden CD, Carlino-MacDonald UB, Beanan JM, Olson R, Wilding GE (2003) The Siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidate. Infect Immun 71(12):7164–7169CrossRefPubMedPubMedCentral Russo TA, McFadden CD, Carlino-MacDonald UB, Beanan JM, Olson R, Wilding GE (2003) The Siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidate. Infect Immun 71(12):7164–7169CrossRefPubMedPubMedCentral
41.
go back to reference Feldmann F, Sorsa LJ, Hildinger K, Schubert S (2007) The salmochelin siderophore receptor IroN contributes to invasion of urothelial cells by extraintestinal pathogenic Escherichia coli in vitro. Infect Immun 75(6):3183–3187CrossRefPubMedPubMedCentral Feldmann F, Sorsa LJ, Hildinger K, Schubert S (2007) The salmochelin siderophore receptor IroN contributes to invasion of urothelial cells by extraintestinal pathogenic Escherichia coli in vitro. Infect Immun 75(6):3183–3187CrossRefPubMedPubMedCentral
42.
go back to reference Gao Q, Wang X, Xu H, Xu Y, Ling J, Zhang D, Gao S, Liu X (2012) Roles of iron acquisition systems in virulence of extraintestinal pathogenic Escherichia coli: salmochelin and aerobactin contribute more to virulence than heme in a chicken infection model. BMC Microbiol 12:143CrossRefPubMedPubMedCentral Gao Q, Wang X, Xu H, Xu Y, Ling J, Zhang D, Gao S, Liu X (2012) Roles of iron acquisition systems in virulence of extraintestinal pathogenic Escherichia coli: salmochelin and aerobactin contribute more to virulence than heme in a chicken infection model. BMC Microbiol 12:143CrossRefPubMedPubMedCentral
43.
go back to reference Koga VL, Tomazetto G, Cyoia PS, Neves MS, Vidotto MC, Nakazato G, Kobayashi RK (2014) Molecular screening of virulence genes in extraintestinal pathogenic Escherichia coli isolated from human blood culture in Brazil. Biomed Res Int 2014:465054 Koga VL, Tomazetto G, Cyoia PS, Neves MS, Vidotto MC, Nakazato G, Kobayashi RK (2014) Molecular screening of virulence genes in extraintestinal pathogenic Escherichia coli isolated from human blood culture in Brazil. Biomed Res Int 2014:465054
44.
go back to reference Cusumano CK, Hung CS, Chen SL, Hultgren SJ (2010) Virulence plasmid harbored by uropathogenic Escherichia coli functions in acute stages of pathogenesis. Infect Immun 78(4):1457–1467CrossRefPubMedPubMedCentral Cusumano CK, Hung CS, Chen SL, Hultgren SJ (2010) Virulence plasmid harbored by uropathogenic Escherichia coli functions in acute stages of pathogenesis. Infect Immun 78(4):1457–1467CrossRefPubMedPubMedCentral
45.
go back to reference Smajs D, Weinstock GM (2001) The iron- and temperature-regulated cjrBC genes of Shigella and enteroinvasive Escherichia coli strains code for colicin Js uptake. J Bacteriol 183(13):3958–3966CrossRefPubMedPubMedCentral Smajs D, Weinstock GM (2001) The iron- and temperature-regulated cjrBC genes of Shigella and enteroinvasive Escherichia coli strains code for colicin Js uptake. J Bacteriol 183(13):3958–3966CrossRefPubMedPubMedCentral
46.
go back to reference Parham NJ, Pollard SJ, Chaudhuri RR, Beatson SA, Desvaux M, Russell MA, Ruiz J, Fivian A, Vila J, Henderson IR (2005) Prevalence of pathogenicity island IICFT073 genes among extraintestinal clinical isolates of Escherichia coli. J Clin Microbiol 43(5):2425–2434CrossRefPubMedPubMedCentral Parham NJ, Pollard SJ, Chaudhuri RR, Beatson SA, Desvaux M, Russell MA, Ruiz J, Fivian A, Vila J, Henderson IR (2005) Prevalence of pathogenicity island IICFT073 genes among extraintestinal clinical isolates of Escherichia coli. J Clin Microbiol 43(5):2425–2434CrossRefPubMedPubMedCentral
47.
go back to reference Wang MC, Tseng CC, Wu AB, Huang JJ, Sheu BS, Wu JJ (2009) Different roles of host and bacterial factors in Escherichia coli extra-intestinal infections. Clin Microbiol Infect 15(4):372–379CrossRefPubMed Wang MC, Tseng CC, Wu AB, Huang JJ, Sheu BS, Wu JJ (2009) Different roles of host and bacterial factors in Escherichia coli extra-intestinal infections. Clin Microbiol Infect 15(4):372–379CrossRefPubMed
Metadata
Title
Clinical and microbiological characteristics of peritoneal dialysis-related peritonitis caused by Escherichia coli in southern Taiwan
Authors
Wei-Hung Lin
Chin-Chung Tseng
An-Bang Wu
Yu-Tzu Chang
Te-Hui Kuo
Jo-Yen Chao
Ming-Cheng Wang
Jiunn-Jong Wu
Publication date
01-09-2018
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 9/2018
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-018-3302-y

Other articles of this Issue 9/2018

European Journal of Clinical Microbiology & Infectious Diseases 9/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.